Novel Antiviral Drugs, Hepatitis B Vaccine Make Elimination Of Chronic Disease Possible, Blog Post Says

PLOS Blogs’ “Speaking of Medicine”: Perspectives Toward the Elimination of Hepatitis B
Guangxiang (George) Luo, professor at the University of Alabama’s Birmingham School of Medicine and the Peking University Health Science Center, “discusses recent advances in antiviral drug development and hepatitis B immunization which hold great promise for achieving the WHO goal of eliminating viral hepatitis by 2030.” He writes, “[I]t is feasible to eliminate chronic hepatitis B given the current advances in the discovery and development of novel antiviral drugs and scale-up of HBV vaccination. The key toward the elimination of hepatitis B lies in the commitment of WHO member state governments in their investments in basic and translational biomedical research and implementation and reinforcement of universal HBV immunization…” (7/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.